Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma.
Bmc Genomics
Dimitrakopoulos, Christos C; Hindupur, Sravanth Kumar SK; Colombi, Marco M; Liko, Dritan D; Ng, Charlotte K Y CKY; Piscuoglio, Salvatore S; Behr, Jonas J; Moore, Ariane L AL; Singer, Jochen J; Ruscheweyh, Hans-Joachim HJ; Matter, Matthias S MS; Mossmann, Dirk D; Terracciano, Luigi M LM; Hall, Michael N MN; Beerenwinkel, Niko N
Publication Date: 2021-08-04
Variant appearance in text: EGFR: 2509G>T; Asp837Tyr
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.
The Oncologist
Ikeda, Sadakatsu S; Tsigelny, Igor F IF; Skjevik, Åge A ÅA; Kono, Yuko Y; Mendler, Michel M; Kuo, Alexander A; Sicklick, Jason K JK; Heestand, Gregory G; Banks, Kimberly C KC; Talasaz, AmirAli A; Lanman, Richard B RB; Lippman, Scott S; Kurzrock, Razelle R
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.
British Journal Of Cancer
Kuiper, J L JL; Hashemi, S M S SM; Thunnissen, E E; Snijders, P J F PJ; Grünberg, K K; Bloemena, E E; Sie, D D; Postmus, P E PE; Heideman, D A M DA; Smit, E F EF
Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.